Pharmacotherapy Casebook: A Patient-Focused Approach, 10E (Pharmacy) by Terry L. Schwinghammer

Author:Terry L. Schwinghammer [Schwinghammer, Terry L.]
Language: eng
Format: azw3
Publisher: McGraw-Hill Education
Published: 2017-06-22T04:00:00+00:00

CLINICAL PEARL

With effective pharmacotherapy available for the acute and long-term therapy of GAD, the treatment goal for anxiety is remission. Many patients exhibit treatment response but still have anxiety symptoms and social and functional impairment. Remission is a more rigorous treatment goal that requires a HAM-A score of ≤7 or reduction of at least 70% in baseline levels of symptoms.

REFERENCES

1. Hamilton M. Hamilton Anxiety Scale. In: Guy W, ed. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD, U.S. Department of Health, Education, Welfare, 1976:193–198.

2. Baldwin DS, Anderson IM, Nutt DJ, et al. Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive–compulsive disorder: a re-vision of the 2005 guidelines from the British Association for Pharmacology. J Psychopharmacol 2014;28:403–439.

3. Davidson JR, Zhang W, Connor KM, et al. A psychopharmacological treatment algorithm for generalized anxiety disorder (GAD). J Psychopharmacol 2010;24:3–26.

4. Zhang Y, Huang G, Yang S, Liang W, Zhang L, Wang C. Duloxetine in treating generalized anxiety disorder in adults: a meta-analysis of published randomized, double-blind, placebo-controlled trials. Asia Pac Psychiatry 2015. doi:10.1111/appy.12203.

5. Bandelow B, Sher L, Bunevicius R, et al. Guidelines for the pharmacological treatment of anxiety disorders, obsessive–compulsive disorder and posttraumatic stress disorder in primary care. Int J Psychiatry Clin Pract 2012;16:77–84.

6. Frampton JE. Pregabalin: a review of its use in adults with generalized anxiety disorder. CNS Drugs 2014;28:835–854.

7. Maneeton N, Maneeton B, Woottiluk P, et al. Quetiapine monotherapy in acute treatment of generalized anxiety disorder: a systematic review and meta-analysis of randomized controlled trials. Drug Des Devel Ther 2016;10:259–276.

8. Sarris J, LaPorte E, Schweitzer I. Kava: a comprehensive review of efficacy, safety, and psychopharmacology. Aust N Z J Psychiatry 2011;45:27–35.

Download

Copyright Disclaimer:
This site does not store any files on its server. We only index and link to content provided by other sites. Please contact the content providers to delete copyright contents if any and email us, we'll remove relevant links or contents immediately.